Bartkowski R, Berger M R, Aguiar J L, Henne T H, Dörsam J, Geelhaar G H, Schlag P, Herfarth C
J Cancer Res Clin Oncol. 1986;111(1):42-6. doi: 10.1007/BF00402774.
For the investigation of locoregional chemotherapy of liver neoplasms we developed a standardized animal model in the rat. Continuous infusion therapy or repeated bolus injections of FUDR or 5-FU were given via the hepatic artery, the portal vein or the vena cava in tumor-bearing animals. The efficacy of the treatment was determined by measuring the tumor volume 3 weeks after tumor cell implantation. For the evaluation of the local and systemic toxicity serum GOT, GPT, and total bilirubin were determined. DNA single strand breaks were assessed in isolated liver and bone marrow cells. Inhibition of colony formation of bone marrow stem cells was determined by CFU-C and CFU-S bioassay. A significant reduction of tumor growth was observed only after continuous infusion of FUDR via the hepatic artery. Systemic toxicity was lowest in this group for both compounds while the local liver toxicity was only slightly elevated.
为了研究肝脏肿瘤的局部区域化疗,我们在大鼠中建立了标准化的动物模型。对荷瘤动物通过肝动脉、门静脉或腔静脉持续输注治疗或重复推注氟尿苷(FUDR)或5-氟尿嘧啶(5-FU)。在肿瘤细胞植入3周后通过测量肿瘤体积来确定治疗效果。为了评估局部和全身毒性,测定血清谷草转氨酶(GOT)、谷丙转氨酶(GPT)和总胆红素。在分离的肝脏和骨髓细胞中评估DNA单链断裂情况。通过集落形成单位-粒细胞(CFU-C)和集落形成单位-脾细胞(CFU-S)生物测定法来确定骨髓干细胞集落形成的抑制情况。仅在通过肝动脉持续输注FUDR后观察到肿瘤生长显著降低。该组中两种化合物的全身毒性最低,而局部肝脏毒性仅略有升高。